Abiopharma

🔍 LEDERMAN SETH (Director)

Company: Tonix Pharmaceuticals Holding Corp. (TNXP)

Report Date: 2026-06-09

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Stock, $0.001 par value at $11.79 per share (Direct)
  Date: 2026-06-09 | Code: P | equity_swap_involved: 0 | shares_owned_after: 9,005.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock, $0.001 par value (Direct)
  Date: 2026-06-09 | Code: H | nature_of_ownership: By IRA Account | shares_owned_after: 20,001.00 | Footnotes: F2
• Holds 0 shares of Common Stock, $0.001 par value (Direct)
  Date: 2026-06-09 | Code: H | nature_of_ownership: Lederman & Co. | shares_owned_after: 1.00 | Footnotes: F2

Footnotes:

• F1: Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.735 to $11.883 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
• F2: Reporting Person may be deemed a control person of this entity.